Document is current

Any future updates will be listed below

Dose-dependent efficacy and safety of Filgotinib in moderate to severe Crohn’s disease: a grade-assessed systematic review and meta-analysis of randomized controlled trials

Crossref DOI link: https://doi.org/10.1007/s00228-025-03891-x

Published Online: 2025-08-02

Published Print: 2025-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark